| Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature G Lughezzani, M Burger, V Margulis, SF Matin, G Novara, M Roupret, ... European urology 62 (1), 100-114, 2012 | 440 | 2012 |
| Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis M Sun, R Thuret, F Abdollah, G Lughezzani, J Schmitges, Z Tian, ... European urology 59 (1), 135-141, 2011 | 345 | 2011 |
| Serum isoform [− 2] proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2–10 ng/ml: a multicentric European study M Lazzeri, A Haese, A de la Taille, JP Redorta, T McNicholas, ... European urology 63 (6), 986-994, 2013 | 266 | 2013 |
| Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between … G Guazzoni, L Nava, M Lazzeri, V Scattoni, G Lughezzani, C Maccagnano, ... European urology 60 (2), 214-222, 2011 | 257 | 2011 |
| Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study A Centemero, L Rigatti, D Giraudo, M Lazzeri, G Lughezzani, D Zugna, ... European urology 57 (6), 1039-1044, 2010 | 249 | 2010 |
| The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation G Lughezzani, M Sun, P Perrotte, C Jeldres, A Alasker, H Isbarn, ... European journal of cancer 46 (4), 713-719, 2010 | 239 | 2010 |
| A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma G Lughezzani, C Jeldres, H Isbarn, SF Shariat, M Sun, D Pharand, ... Urology 75 (1), 118-124, 2010 | 183 | 2010 |
| Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients G Lughezzani, C Jeldres, H Isbarn, M Sun, SF Shariat, A Alasker, ... European Journal of Cancer 45 (18), 3291-3297, 2009 | 173 | 2009 |
| Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment M Crépel, C Jeldres, P Perrotte, U Capitanio, H Isbarn, SF Shariat, ... Urology 75 (2), 271-275, 2010 | 163 | 2010 |
| Preoperative prostate-specific antigen isoform p2PSA and its derivatives,% p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical … G Guazzoni, M Lazzeri, L Nava, G Lughezzani, A Larcher, V Scattoni, ... European urology 61 (3), 455-466, 2012 | 155 | 2012 |
| Clinical performance of serum prostate‐specific antigen isoform [‐2] proPSA (p2PSA) and its derivatives,% p2PSA and the prostate health index (PHI), in men with a family … M Lazzeri, A Haese, A Abrate, A de la Taille, JP Redorta, T McNicholas, ... BJU international 112 (3), 313-321, 2013 | 153 | 2013 |
| Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature G Lughezzani, A Briganti, PI Karakiewicz, MW Kattan, F Montorsi, ... European urology 58 (5), 687-700, 2010 | 153 | 2010 |
| Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database G Lughezzani, M Sun, P Perrotte, SF Shariat, C Jeldres, L Budäus, ... Urology 75 (2), 321-327, 2010 | 152 | 2010 |
| Margin, ischemia, and complications (MIC) score in partial nephrectomy: a new system for evaluating achievement of optimal outcomes in nephron-sparing surgery. N Buffi, G Lista, A Larcher, G Lughezzani, V Ficarra, A Cestari, M Lazzeri, ... European urology 62 (4), 617-618, 2012 | 151 | 2012 |
| Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter C Jeldres, G Lughezzani, M Sun, H Isbarn, SF Shariat, L Budaus, ... The Journal of urology 183 (4), 1324-1329, 2010 | 140 | 2010 |
| Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma H Isbarn, C Jeldres, SF Shariat, D Liberman, M Sun, G Lughezzani, ... The Journal of urology 182 (5), 2177-2181, 2009 | 140 | 2009 |
| Role of restaging transurethral resection for T1 non–muscle invasive bladder cancer: a systematic review and meta-analysis A Naselli, R Hurle, S Paparella, NM Buffi, G Lughezzani, G Lista, ... European urology focus 4 (4), 558-567, 2018 | 130 | 2018 |
| Treatment of metastatic renal cell carcinoma M Sun, G Lughezzani, P Perrotte, PI Karakiewicz Nature Reviews Urology 7 (6), 327-338, 2010 | 125 | 2010 |
| Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study G Lughezzani, M Sun, P Perrotte, SF Shariat, C Jeldres, L Budaus, ... European urology 57 (6), 956-962, 2010 | 122 | 2010 |
| A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma C Jeldres, M Sun, H Isbarn, G Lughezzani, L Budäus, A Alasker, ... Urology 75 (2), 315-320, 2010 | 120 | 2010 |
